Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis

Autoimmunity

Volumn 42, Issue 2, 2009, Pages 143-149

  Morimoto, Shinji ^a   Tokano, Yoshiaki ^a   Nakano, Souichiro ^a   Watanabe, Takashi ^a   Tamayama, Yoshihiro ^a   Mitsuo, Akiko ^a   Suzuki, Jun ^a   Kaneko, Hiroshi ^a   Sekigawa, Iwao ^a   Takasaki, Yoshinari ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD62L expression; Chemokine; IFN production; Proliferative lupus nephritis; Th1 producing cell

Indexed keywords

DNA ANTIBODY; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHEMOKINE CXCL10; CHEMOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-18; INTERLEUKIN-2; INTERLEUKINS; L-SELECTIN; LUPUS NEPHRITIS; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 58949102222     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802438790     Document Type: Article

References (38)

1. Houssiau, FA (2004) Management of lupus nephritis: An update. J Am Soc Nephrol, 15, pp. 2694-2704.
2. Tokano, Y., Morimoto, S., Kaneko, H., Amano, H., Nozawa, K., Takasaki, Y. and Hashimoto, H. (1999) Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol, 116, pp. 169-173.
3. Appel, GB, Cohen, DJ, Pirani, CL, Meltzer, JI and Estes, D. (1987) Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med, 83, pp. 877-885.
4. Esdaile, JM, Levinton, C., Federgreen, W., Hayslett, JP and Kashgarian, M. (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: A study of 87 patients and review of the literature. Q J Med, 72, pp. 779-833.
5. McLaughlin, J., Gladman, DD, Urowitz, MB, Bombardier, C., Farewell, VT and Cole, E. (1991) Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum, 34, pp. 1268-1273.
6. McLaughlin, JR, Bombardier, C., Farewell, VT, Gladman, DD and Urowitz, MB (1994) Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum, 37, pp. 559-567.
7. Sesso, R., Monteiro, M., Sato, E., Kirsztajn, G., Silva, L. and Ajzen, H. (1994) A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis. Lupus, 3, pp. 107-112.
8. Kashgarian, M. (1997) Lupus nephritis: Patology, pathogenesis, clinical correlations, and prognosis. Duboi's lupus erythematosus, pp. 1037-1051.
9. Mosmann, TR and Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today, 17, pp. 138-146.
10. Masutani, K., Akahoshi, M., Tsuruya, K., Tokumoto, M., Ninomiya, T., Kohsaka, T., Fukuda, K., Kanai, H., Nakashima, H., Otsuka, T. and Hirakata, H. (2001) Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum, 44, pp. 2097-2106.
11. Rovin, BH, Rumancik, M., Tan, L. and Dickerson, J. (1994) Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest, 71, pp. 536-542.
12. Tipping, PGKA and Holdworth, SR (2001) The Formation of Glomerular Crescents, Lippincott Williams & Wilkins, Phildelphia, PA
13. Allavena, P., Bianchi, G., Zhou, D., van Damme, J., Jilek, P., Sozzani, S. and Mantovani, A. (1994) Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol, 24, pp. 3233-3236.
14. Carr, MW, Roth, SJ, Luther, E., Rose, SS and Springer, TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA, 91, pp. 3652-3656.
15. Valente, AJ, Graves, DT, Vialle-Valentin, CE, Delgado, R. and Schwartz, CJ (1988) Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry, 27, pp. 4162-4168.
16. Gerard, C. and Rollins, BJ (2001) Chemokines and disease. Nat Immunol, 2, pp. 108-115.
17. Harigai, M., Hara, M., Yoshimura, T., Leonard, EJ, Inoue, K. and Kashiwazaki, S. (1993) Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol, 69, pp. 83-91.
18. Wada, T., Furuichi, K., Segawa-Takaeda, C., Shimizu, M., Sakai, N., Takeda, SI, Takasawa, K., Kida, H., Kobayashi, KI, Mukaida, N., Ohmoto, Y., Matsushima, K. and Yokoyama, H. (1999) MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int, 56, pp. 995-1003.
19. Wada, T., Yokoyama, H., Su, SB, Mukaida, N., Iwano, M., Dohi, K., Takahashi, Y., Sasaki, T., Furuichi, K., Segawa, C., Hisada, Y., Ohta, S., Takasawa, K., Kobayashi, K. and Matsushima, K. (1996) Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int, 49, pp. 761-767.
20. Rovin, BH and Phan, LT (1998) Chemotactic factors and renal inflammation. Am J Kidney Dis, 31, pp. 1065-1084.
21. Zoja, C., Liu, XH, Donadelli, R., Abbate, M., Testa, D., Corna, D., Taraboletti, G., Vecchi, A., Dong, QG, Rollins, BJ, Bertani, T. and Remuzzi, G. (1997) Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol, 8, pp. 720-729.
22. Tesch, GH, Maifert, S., Schwarting, A., Rollins, BJ and Kelley, VR (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas[lpr] mice. J Exp Med, 190, pp. 1813-1824.
23. Gong, JH, Ratkay, LG, Waterfield, JD and Clark-Lewis, I. (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med, 186, pp. 131-137.
24. Tan, EM, Cohen, AS, Fries, JF, Masi, AT, McShane, DJ, Rothfield, NF, Schaller, JG, Talal, N. and Winchester, RJ (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25, pp. 1271-1277.
25. Bombardier, C., Gladman, DD, Urowitz, MB, Caron, D. and Chang, CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 35, pp. 630-640.
26. Sugimoto, K., Morimoto, S., Kaneko, H., Nozawa, K., Tokano, Y., Takasaki, Y. and Hashimoto, H. (2002) Decreased IL-4 producing CD4+T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression. Autoimmunity, 35, pp. 381-387.
27. Kaneko, H., Ogasawara, H., Naito, T., Akimoto, H., Lee, S., Hishikawa, T., Sekigawa, I., Tokano, Y., Takasaki, Y., Hirose, SI and Hashimoto, H. (1999) Circulating levels of beta-chemokines in systemic lupus erythematosus. J Rheumatol, 26, pp. 568-573.
28. Morimoto, S., Tokano, Y., Kaneko, H., Nozawa, K., Amano, H. and Hashimoto, H. (2001) The increased interleukin-13 in patients with systemic lupus erythematosus: Relations to other Th1- Th2-related cytokines and clinical findings. Autoimmunity, 34, pp. 19-25.
29. Arbones, ML, Ord, DC, Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, DJ and Tedder, TF (1994) Lymphocyte homing and leukocyte rolling and migration are impaired in -selectin-deficient mice. Immunity, 1, pp. 247-260.
30. Csiszar, A., Nagy, G., Gergely, P., Pozsonyi, T. and Pocsik, E. (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol, 122, pp. 464-470.
31. Esfandiari, E., McInnes, IB, Lindop, G., Huang, FP, Field, M., Komai-Koma, M., Wei, X. and Liew, FY (2001) A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol, 167, pp. 5338-5347.
32. Tang, ML, Steeber, DA, Zhang, XQ and Tedder, TF (1998) Intrinsic differences in -selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J Immunol, 160, pp. 5113-5121.
33. Gauguet, JM, Rosen, SD, Marth, JD and von Andrian, UH (2004) Core 2 branching beta1,6-N-acetylglucosaminyltransferase and high endothelial cell N-acetylglucosamine-6-sulfotransferase exert differential control over B- and T-lymphocyte homing to peripheral lymph nodes. Blood, 104, pp. 4104-4112.
34. Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, CH, Young, SG, Rollins, BJ and Charo, IF (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest, 103, pp. 773-778.
35. Lee, SK, Kim, BS, Yang, WS, Kim, SB, Park, SK and Park, JS (2001) High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int, 60, pp. 55-64.
36. Romagnani, P., Lazzeri, E., Lasagni, L., Mavilia, C., Beltrame, C., Francalanci, M., Rotondi, M., Annunziato, F., Maurenzig, L., Cosmi, L., Galli, G., Salvadori, M., Maggi, E. and Serio, M. (2002) IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol, 13, pp. 53-64.
37. Papadakis, KA, Zhu, D., Prehn, JL, Landers, C., Avanesyan, A., Lafkas, G. and Targan, SR (2005) Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+T lymphocytes. J Immunol, 174, pp. 4985-4990.
38. Tokano, Y., Suzuki, J., Amano, H., Nozawa, K., Morimoto, S. and Hashimoto, H. (2002) Increased levels of interleukin-18 in patients with systemic lupus erythematosus: Comment on the article by Shibatomi et al. Arthritis Rheum, 46, pp. 1410-1411.